JPRN-UMIN000011891已完成未知
Multicenter study of the effect of GoLimumab On the Remission Induction rate and bio-free remission maintenance rate in early rheumatoid Arthritis. - GLORIA study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.progressive interstitial lung disease 2.HBV and/or HCV carier 3.History of any biologic DMARDs use 4.Seriou infection, active tuberculosis, demyelinating disease, or congestive heart failure
研究者
相似试验
进行中（未招募）
1 期
Pilot study on the efficacy of golimumab in normalizing the symptoms and lesions of the colon-rectum in patients with ulcerative colitis who only respond to therapy with cortisoneactive steroid-dependent ulcerative colitisMedDRA version: 17.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2014-002579-27-ITIstituto Clinico Humanitas100
招募中
4 期
Prospective follow-up study of golimumab treatment in ankylosing spondylitis.1000381610023213Ankylosing SpondylitisNL-OMON41382Jan van Breemen Instituut100
尚未招募
4 期
Prospective follow-up study of golimumab treatment in psoriatic arthritis100038161002321310014982psoriatic arthritisNL-OMON37425Jan van Breemen Instituut100
已完成
3 期
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)Spondylitis, AnkylosingNCT01453725Merck Sharp & Dohme LLC198
已完成
3 期
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)Arthritis, RheumatoidNCT00299546Centocor, Inc.461